New universal platform for cancer immunotherapy
Monday, March 5, 2012 - 23:30
in Health & Medicine
Researchers report a universal approach to personalized cancer therapy based on T cells. It is the first time a system for making an adaptable, engineered T-cell to attack specific tumor types has been proposed, depending on which abnormal proteins, called antigens, are expressed by individual patients' tumor cells.